help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on July 12, 2005
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-0105
A more recent version of this article appeared on October 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
90/10/5656    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giordano, R.
Right arrow Articles by Arvat, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giordano, R.
Right arrow Articles by Arvat, E.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*HYDROCORTISONE
*SPIRONOLACTONE
Medline Plus Health Information
*Seniors' Health

Submitted on January 18, 2005
Accepted on July 6, 2005

HYPOTHALAMUS-PITUITARY-ADRENAL HYPERACTIVITY IN HUMAN AGING IS PARTIALLY REFRACTORY TO STIMULATION BY MINERALOCORTICOID RECEPTOR BLOCKADE

Roberta Giordano, Mario Bo, Micaela Pellegrino, Marco Vezzari, Matteo Baldi, Andreea Picu, Marcella Balbo, Lorenza Bonelli, Giuseppe Migliaretti, Ezio Ghigo, and Emanuela Arvat*

Division of Endocrinology and Metabolism, Department of Internal Medicine, Department of Medical and Surgical Disciplines, Section of Geriatrics, Department of Public Health and Microbiology, University of Turin, Italy

* To whom correspondence should be addressed. E-mail: emanuela.arvat{at}unito.it.

Context: HPA axis is mainly regulated by CRH, AVP and glucocorticoid feedback. Hippocampal mineralcorticoid receptors (MRs) mediate proactive glucocorticoid feedback and mineralocorticoid antagonists, accordingly, stimulate HPA axis. Age-related HPA hyperactivity reflects impaired glucocorticoid feedback at the suprapituitary level.

Design: ACTH, cortisol and DHEA secretion were studied in 8 healthy elderly subjects (ES, 75.1 ± 3.2 yr) and 8 young subjects (YS, 25.0 ± 4.6 yr) during placebo or canrenoate (CAN, 200 mg i.v. bolus followed by 200 mg infused over 4 h).

Results: During placebo, ACTH and cortisol AUCs in ES were higher than in YS (P ≤ 0.01); conversely, DHEA AUCs in ES were lower than in YS (P = 0.002). CAN increased ACTH, cortisol and DHEA levels in both groups. In YS, both ACTH, cortisol and DHEA levels at the end of CAN infusion were higher (P ≤ 0.05) than after placebo. In ES, at the end of CAN infusion ACTH, cortisol and DHEA levels were higher (P = 0.01) than after placebo. Under CAN, ACTH and cortisol AUCs persisted higher (P ≤ 0.01) and DHEA AUCs lower (P = 0.006) in ES than in YS. Cortisol AUCs after CAN in YS did not become significantly different from those in ES after placebo.

Conclusions: i) evening-time ACTH and cortisol secretion in ES is higher than in YS; ii) ACTH and cortisol secretion in ES is enhanced by CAN but less than in YS; iii) DHEA hyposecretion in ES is partially restored by mineralocorticoid antagonism. Age-related variations of HPA activity may be determined by some derangement in MRs function at the hippocampal level.


Key words: glucocorticoid feedback • canrenoate • HPA • DHEA • aging







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society